Example GWAS-QTL colocalization plots are in Fig.S19, including the novel female-biased SHC3 locus where SEMA4D was prioritized, a glial activation gene already targeted by Pepinemab in phase1/2 AD clinical trials47. The gene discussed is SEMA4D; the disease is Alzheimer disease.